Research into long COVID may benefit other fatigue syndromes that follow infections. These difficult to diagnose and treat disorders affect twice as many women as men. A symbol of sexism in medicine?<\/p>\n
\u201cWhen we started talking about long COVID at the end of 2020, patients told me how close it was to their symptoms,\u201d says Durand, epidemiologist from the Universit\u00e9 de Montr\u00e9al who studied a cohort of patients with long COVID. \u201cThese are patients who for years had chronic fatigue, mental fog, abnormally low resistance to exertion. Doctors often told them it was in their heads. These are symptoms that are called “non-specific.” There are no diagnostic tests.\u201d<\/p>\n
These problems are often grouped under the term \u201cacute post-infection syndrome.\u201d \u201cThe idea is that there are things that have changed with the infection, and there are still sequelae that we can\u2019t measure right now,\u201d says Durand. \u201cSince many people have had COVID-19, there are many cases of long COVID. We are talking about 15% of COVID-19 cases. So there\u2019s a lot of funding for long COVID.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
Research into long COVID may benefit other fatigue syndromes that follow infections. These difficult to diagnose and treat disorders affect twice as many women as men. A symbol of sexism in medicine?<\/p>\n
\u201cWhen we started talking about long COVID at the end of 2020, patients told me how close it was to their symptoms,\u201d says Durand, epidemiologist from the Universit\u00e9 de Montr\u00e9al who studied a cohort of patients with long COVID. \u201cThese are patients who for years had chronic fatigue, mental fog, abnormally low resistance to exertion. Doctors often told them it was in their heads. These are symptoms that are called “non-specific.” There are no diagnostic tests.\u201d<\/p>\n
These problems are often grouped under the term \u201cacute post-infection syndrome.\u201d \u201cThe idea is that there are things that have changed with the infection, and there are still sequelae that we can\u2019t measure right now,\u201d says Durand. \u201cSince many people have had COVID-19, there are many cases of long COVID. We are talking about 15% of COVID-19 cases. So there\u2019s a lot of funding for long COVID.\u201d<\/p>\n